Surrey Capital

Surrey Capital Partners is a private life sciences-focused investment firm and impact fund based in New York. The firm appears to invest in early- to mid-stage biotech, healthcare, medical device, and health technology companies rather than operating as a drug-development company itself. Public descriptions associate the firm with founder Samantha Surrey and position it as a healthcare innovation fund seeking transformational opportunities across biopharma, medical devices, AI for healthcare, and related areas. Available public information suggests it is an active investment organization, although some private-market databases characterize it as inactive or historical, so operating status should be treated with caution.